Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia

BACKGROUND: The progression of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) dementia can be predicted by cognitive, neuroimaging, and cerebrospinal fluid (CSF) markers. Since most biomarkers reveal complementary information, a combination of biomarkers may increase the predictive powe...

Descripción completa

Detalles Bibliográficos
Autores principales: Frölich, Lutz, Peters, Oliver, Lewczuk, Piotr, Gruber, Oliver, Teipel, Stefan J., Gertz, Hermann J., Jahn, Holger, Jessen, Frank, Kurz, Alexander, Luckhaus, Christian, Hüll, Michael, Pantel, Johannes, Reischies, Friedel M., Schröder, Johannes, Wagner, Michael, Rienhoff, Otto, Wolf, Stefanie, Bauer, Chris, Schuchhardt, Johannes, Heuser, Isabella, Rüther, Eckart, Henn, Fritz, Maier, Wolfgang, Wiltfang, Jens, Kornhuber, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634868/
https://www.ncbi.nlm.nih.gov/pubmed/29017593
http://dx.doi.org/10.1186/s13195-017-0301-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634868/
https://www.ncbi.nlm.nih.gov/pubmed/29017593
http://dx.doi.org/10.1186/s13195-017-0301-7

Ejemplares similares